ON POINT

What this means for you

Not registered yet, but its 08 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99175610

Mark type

Stylized text

Filed

08 May 2025

Attorney of record

Aaron D. Hendelman

Goods and services

• Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of and prevention of musculoskeletal, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, and muscle atrophy related diseases and disorders; pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; therapeutic pharmaceutical for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; therapeutic pharmaceuticals for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; none of the foregoing related to pharmacy services or pharmaceutical compounding services
• Class 040 — Treatment of materials: Custom manufacturing of oligonucleotide-conjugate based pharmaceutical therapies, oligonucleotide-antibody conjugate based pharmaceutical therapies, and oligonucleotide-antibody fragment conjugate based pharmaceutical therapies; custom manufacturing of pharmaceuticals; contract manufacturing in the field of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; none of the foregoing related to pharmacy services or pharmaceutical compounding services
• Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the fields of pharmaceuticals, biotechnology, and clinical trials; pharmaceutical research and development; pharmaceutical products development; research and development in the field of biotechnology; providing medical and scientific research information in the fields of pharmaceuticals, therapeutics, medicines and vaccines; none of the foregoing related to pharmacy services or pharmaceutical compounding services
• Class 044 — Medical, beauty and agricultural services: Providing information relating to the diagnostic, prophylactic and therapeutic properties in the field of pharmaceuticals, therapeutics, medicines, and vaccines; online medical information services, namely, providing a website related to the diagnostic, prophylactic and therapeutic properties of medicines and vaccines; none of the foregoing related to medical care centers, medical services, medical clinics, pharmacy services, pharmaceutical compounding services, administration of pharmaceutical preparations, or drop-in medical clinics

Owner

• Avidity Biosciences, Inc., San Diego, CA, US

Prosecution history

• 27 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 05 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 05 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 05 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 05 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 04 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 04 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 17 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 17 Oct 2025 — NON-FINAL ACTION E-MAILED
• 17 Oct 2025 — NON-FINAL ACTION WRITTEN
• 16 Oct 2025 — ASSIGNED TO EXAMINER
• 24 Sept 2025 — ASSIGNED TO EXAMINER